As pharmaceutical organisations face a convergence of pressures - accelerating time-to-market expectations, increasing manufacturing complexity, growing reliance on CDMOs, intensifying sustainability and regulatory demands - tech transfer from R&D to Manufacturing is a consistent and often underestimated bottleneck.
This white paper, developed jointly by DTG and NGT Biopharma Consultants argues that the root cause of these challenges is not a lack of digital tools, but a failure to ensure data continuity across the pharmaceutical supply chain - so that best practice travels with the molecule through tech transfer rather than being rebuilt from scratch at each handoff.
The White Paper explores:
- The distinction between digital systems and digital readiness
- Where value is being lost in the process
- The psychology of trust in pdfs and data
- Leadership, Mindset and the Operating Model
- Rethinking the CDMO Ecosystem from fragmentation to platforms
- Sustainability as a Catalyst
- The Future State
- The Practical Factors Critical to Success
